CTLA-4 Control over Foxp3 + Regulatory T Cell Function

American Association for the Advancement of Science (AAAS) - Tập 322 Số 5899 - Trang 271-275 - 2008
Kajsa Wing1,2,3,4, Yasushi Onishi1,2,3,4, Paz Prieto-Martin1,2,3,4, Tomoyuki Yamaguchi1,2,3,4, Makoto Miyara1,2,3,4, Zoltán Fehérvári1,2,3,4, Takashi Nomura1,2,3,4, Shimon Sakaguchi1,2,4
1Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan
2Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
3Department of Rheumatology and Haematology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
4Laboratory of Experimental Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Suita 565-0871, Japan.

Tóm tắt

Naturally occurring Foxp3 + CD4 + regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell–mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs—in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.

Từ khóa


Tài liệu tham khảo

10.1016/j.cell.2008.05.009

10.1016/S1074-7613(00)80195-8

10.1084/jem.192.2.303

10.1084/jem.192.2.295

10.1126/science.1079490

10.1016/j.cell.2006.05.042

10.1038/nature05478

10.1038/nature05563

10.1038/nature05673

10.1126/science.270.5238.985

10.1016/1074-7613(95)90125-6

10.1038/nature05911

10.1126/science.271.5256.1734

10.1073/pnas.1533209100

10.4049/jimmunol.177.7.4376

10.1111/j.0105-2896.2006.00419.x

Materials and methods are available as supporting material on Science Online.

10.1016/S0014-5793(00)01338-7

10.4049/jimmunol.176.8.4748

10.1038/nature05479

J. Shimizu, S. Yamazaki, S. Sakaguchi, J. Immunol.163, 5211 (1999).

10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X

10.1111/j.1365-2567.2006.02362.x

10.1111/j.0105-2896.2006.00422.x

10.4049/jimmunol.179.7.4685

10.1073/pnas.0711106105

We thank M. Ono for discussion and R. Ishii and M. Matsushita for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education Sports and Culture of Japan Japan Science and Technology Agency. Z.F. was a Japan Society for the Promotion of Science fellow and K.W. was granted a fellowship by Astra-Zeneca Loughborough UK.